ํTWST โข NASDAQ
add
ํธ์์คํธ ๋ฐ์ด์ค์ฌ์ด์ธ์ค
$47.59
์๊ฐ์ธ:(0.50%)+0.24
$47.83
๋ง๊ฐ๋จ:2์ 14์ผ, ์คํ 7์ 41๋ถ 25์ด GMT-5 · USD · NASDAQ · ๋ฉด์ฑ
์กฐํญ
์ ์ผ ์ข
๊ฐ
$46.87
์ผ์ผ ๋ณ๋ํญ
$46.81 - $48.34
52์ฃผ ๋ณ๋ํญ
$27.41 - $60.90
์๊ฐ์ด์ก
28.36์ต USD
ํ๊ท ๊ฑฐ๋๋
83.49๋ง
์ฃผ๊ฐ์์ต๋ฅ
-
๋ฐฐ๋น์์ต๋ฅ
-
๊ธฐ๋ณธ ๊ฑฐ๋์
NASDAQ
๋ด์ค
์ฌ๋ฌด
์์ต๊ณ์ฐ์
์์ต
์์ด์ต
(USD) | 2024๋ 12์info | ์ ๋ ๋๋น ๋ณ๋ |
---|---|---|
์์ต | 8871.30๋ง | 24.08% |
์ด์๋น | 7748.40๋ง | 2.03% |
์์ด์ต | -3159.40๋ง | 26.54% |
์์ด์ต๋ฅ | -35.61 | 40.80% |
์ฃผ๋น ์์ต | -0.53 | 29.33% |
EBITDA | -2826.40๋ง | 27.17% |
์ ํจ ์ธ์จ | -0.31% | โ |
๋์ฐจ๋์กฐํ
์ด์์ฐ
์ด๋ถ์ฑ
(USD) | 2024๋ 12์info | ์ ๋ ๋๋น ๋ณ๋ |
---|---|---|
ํ๊ธ ๋ฐ ๋จ๊ธฐ ํฌ์ | 2.71์ต | -12.96% |
์ด์์ฐ | 6.09์ต | -16.95% |
์ด๋ถ์ฑ | 1.53์ต | 6.91% |
์ด์๊ธฐ์๋ณธ | 4.56์ต | โ |
๋ฐํ ์ฃผ์ | 5965.11๋ง | โ |
์ฃผ๊ฐ์์์ฐ๋น์จ | 6.13 | โ |
์ด์์ฐ์ด์ต๋ฅ | -14.16% | โ |
์๋ณธ์ด์ต๋ฅ | -15.80% | โ |
ํ๊ธ ํ๋ฆ
์ํ๊ธํ๋ฆ
(USD) | 2024๋ 12์info | ์ ๋ ๋๋น ๋ณ๋ |
---|---|---|
์์ด์ต | -3159.40๋ง | 26.54% |
์์
ํ๊ธ ํ๋ฆ | -2142.80๋ง | 6.73% |
ํฌ์ ํ๊ธ ํ๋ฆ | -153.60๋ง | -136.88% |
์๊ธ ์กฐ๋ฌ ํ๊ธ ํ๋ฆ | 1794.40๋ง | 1,318.19% |
์ํ๊ธํ๋ฆ | -507.30๋ง | 74.84% |
์์ฌ ํ๊ธ ํ๋ฆ | -1125.45๋ง | -3.00% |
์ ๋ณด
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
์ค๋ฆฝ
2013
์น์ฌ์ดํธ
์ง์ ์
923